Showing results (21-30 of 62) with videos related to
Sort By:
Pageof 7
The Journal of Nutrition|February 1, 1994
Carbohydrate utilization by rainbow trout is affected by feeding strategyS S Hung, T StorebakkenBiochemical Pharmacology|April 15, 1982
Effect of L-glutamine antagonists on 5-phosphoribosyl 1-pyrophosphate levels in P388 leukemia and in murine colon adenocarcinomas in vivoB Ardalan, M Arakawa, D Villacorte, et al.International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift Fur Vitamin- Und Ernahrungsforschung. Journal International De Vitaminologie Et De Nutrition|January 1, 1980
Effect of oxidized fish oil on the ascorbic acid nutrition of rainbow trout (Salmo gairdneri)S S Hung, S J SlingerInternational Journal for Vitamin and Nutrition Research. Internationale Zeitschrift Fur Vitamin- Und Ernahrungsforschung. Journal International De Vitaminologie Et De Nutrition|January 1, 1982
Effect of dietary vitamin E on rainbow trout (salmo gairdneri). Muscle alpha-tocopherol and storage stabilityS S Hung, S J SlingerToxicology and Applied Pharmacology|April 1, 1985
Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive ratsE H Herman, A N el-Hage, V J Ferrans, et al.Oxford Medical Case Reports|November 28, 2019
Metastatic involvement of skeletal muscle from gastric adenocarcinomaL E Aguirre, J Salcedo, R Zuquello, et al.Cancer Research|January 15, 1988
Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokineticsD V Spicer, B Ardalan, J R Daniels, et al.Journal of Chemotherapy (Florence, Italy)|March 18, 2008
Differential expression of Glut 1 mRNA and protein levels correlates with increased sensitivity to the glyco-conjugated nitric oxide donor (2-glu-SNAP) in different tumor cell typesP R Subbarayan, P G Wang, T J Lampidis, et al.The Journal of Nutrition|October 1, 1993
White sturgeon tissue fatty acid compositions are affected by dietary lipidsR Xu, S S Hung, J B GermanCancer|September 15, 1992
Phase II trial of 4'-0-tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinomaK S Sridhar, A M Hussein, P Benedetto, et al.Pageof 7